FATE CapEx to Revenue

Fate Therapeutics Inc · CapEx to Revenue

FATE logo

FATE CapEx to Revenue

Current (TTM)57.22%
FATE CapEx/Revenue (0.17% → 57.22%)
High-resolution chart · PNG

FATE capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Fate Therapeutics Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
89.5727%
5.3554%
9.6847%
36.9325%
90.7925%
15.69%
69.2416%
48.5865%
42.0117%
10.3816%
61.6207%
0%
25.1287%
26.5543%
0.1709%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.